(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...

Intel's new CEO, Lip-Bu Tan, said on Monday that the company has a 55% share of the data centre market.

Investors reacted positively to the news, as the FDA’s approval not only enhances Novavax’s product offering but also solidifies its partnership with Sanofi, a key player in the vaccine market. The ...

Several Asian countries are witnessing a fresh surge in Covid-19 cases, driven by the fast-spreading JN.1 variant and its ...

Germany's antitrust head Andreas Mundt on Monday addressed mounting concerns about the deviation in approaches between ...